Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
Date:5/2/2013

l of 2013 and patient enrollment of approximately 155 patients is expected to begin in mid-2013. 
  • The Rainier™ Trial is an investigator-sponsored, randomized, placebo-controlled Phase 2 trial evaluating OGX-427 in combination with ABRAXANE® (paclitaxel protein-bound particles for injectable suspension)(albumin-bound) and gemcitabine in approximately 130 patients with previously untreated metastatic pancreatic cancer. Plans for Rainier were announced in May of 2013 and patient enrollment is expected to begin in mid-2013.
  • The Pacific™ Trial is an investigator-sponsored, randomized Phase 2 trial evaluating OGX-427 in approximately 80 men with metastatic castrate-resistant prostate cancer (CRPC) who are experiencing rising prostate-specific antigen (PSA) while receiving Zytiga® (abiraterone acetate). The trial was initiated in December of 2012, and is currently enrolling at sites in the United States and Canada.
  • Custirsen Program Update

  • The primary registration Phase 3 SYNERGY trial, designed to evaluate a survival benefit for custirsen in combination with first-line docetaxel chemotherapy in men with metastatic CRPC, completed enrollment in 2012. The SYNERGY trial is continuing as planned per the recommendation of an independent Data Monitoring Committee (DMC), who have completed the second and last futility analyses per protocol. The planned efficacy interim analysis has not yet occurred. The expected timing of final results is based on a pre-specified number of death events that is projected to occur in the fourth quarter of 2013, with data results expected to be announced in the first half of 2014.
  • Patient enrollment continues in the additional Phase 3 custirsen trials, AFFINITY and ENSPIRIT. The AFFINITY trial will evaluate the potential survival benefit of custirsen in combination with Jevtana® (cabazitaxel) as second-line chemo
    '/>"/>

  • SOURCE OncoGenex Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
    2. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
    3. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
    4. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
    5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
    6. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
    7. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
    8. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
    9. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
    10. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
    11. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... and HOUSTON, TX , ... the "Company") (TSX-V: EPI) and Bloom Burton & Co. ... from voluntary contractual lock-up (the "Lock-Up") 2,353,130 common shares ... Common Shares originally subject to the Lock-Up. Of the ... be free trading immediately upon release from the Lock-Up ...
    (Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation ... in the Barclays 2015 Annual Healthcare Conference on March ... Dan Brennan , executive vice president and ... president, Investor Relations, will participate in a 25-minute question ... analyst at approximately 1:05 p.m. ET. Following a 5-minute ...
    (Date:2/27/2015)... 2015   Synageva BioPharma Corp. (Synageva) ... developing therapeutic products for rare diseases, joins the ... Organisation for Rare Diseases™ (EURORDIS™), The Global Genes ... Rare Disease Day. On the last ... and other participants conduct special events to raise ...
    Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
    ... N.C., Dec. 21, 2010 Charlotte Business Journal ... an affiliate of Diagnostic Devices Inc. – one of ... an awards luncheon held at the Charlotte Convention Center ... recognizes Charlotte area companies for their leadership, entrepreneurial excellence, ...
    ... 21, 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... Executive Officer, will host a conference call and webcast tomorrow, ... a.m. Pacific Time) to provide an update following the completion ... Administration (FDA) for the lorcaserin New Drug Application (NDA). ...
    Cached Medicine Technology:Charlotte Business Journal Honors Prodigy Diabetes Care, LLC With Fast 50 Award 2Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 2Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 3
    (Date:2/28/2015)... MO (PRWEB) February 28, 2015 ... provider of outsourced sales, marketing and supply chain ... client, BIOTA Botanicals, is bringing its award winning ... worldwide, BIOTA Botanicals’ products are specifically created to ... care experts, BIOTA is committed to marrying science ...
    (Date:2/28/2015)... February 28, 2015 India Network ... sponsored visitor health insurance programs for visitors coming to ... Indian elderly parents traveling to the United States are ... diabetes and blood pressure. These diseases are so common ... list them as medical conditions. There were 66.8 million ...
    (Date:2/28/2015)... AZ (PRWEB) February 28, 2015 Kaylie ... and alcohol treatment center , and current student obtaining ... University, has implemented a weekly forum in psychoeducation on ... school in Flagstaff, AZ as part of her studies. ... big need for support and counseling at the high ...
    (Date:2/28/2015)... February 28, 2015 On Thursday, February 26th, ... It Easy For Scammers To Steal Your Data , which ... their hands on a DIY phishing kit, or any kind ... touched on another important point about how everyone’s cyber security ... often implemented, “like compromising legitimate content management systems or blogs ...
    (Date:2/28/2015)... The noted Toronto plastic surgeon Dr. David Ellis ... in the January/February 2015 issue of Elevate magazine. On ... featured in an article entitled “Get the Look: Kim ... Cattrall has possibly undergone to maintain her youthful appearance ... horizontal lines or frown line creases, which can be ...
    Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Dr. David Ellis Featured In Elevate Magazine 2
    ... 16 HHS Secretary Mike,Leavitt today declared a ... and Indiana. The action gives HHS, Centers for ... health care,providers greater flexibility in meeting emergency health ... is devastating to each individual and,to their communities," ...
    ... Technical Staff, and 7 other HFI usability, experts ... and research topics including, ,Who are ... NEW YORK, June 16 Human Factors International ... its "platinum",sponsorship of the 2008 Usability Professionals, Association ...
    ... new family of therapeutic agents that interferes with the ... cancer cells. The results of the new study will ... 90th Annual Meeting in San Francisco. , The ... and related compounds are likely to be effective against ...
    ... CHICAGO Two research studies evaluating dietary changes and ... (IBD) have been launched at Rush University Medical Center. ... study will look at the impact of mind/body medicine ... other will assess how diet impacts patients with Crohn,s ...
    ... of humans with disease, study says , , MONDAY, June 16 ... lives of dogs with cancer may also be able to ... better quality of life, the therapy,s developers say. , ... 55 dogs with cancer and anemia. It increases muscle strength ...
    ... 16 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that it ... of amended,Series B warrants and broker warrants ... in January 2007., "I sincerely thank ...
    Cached Medicine News:Health News:HHS Takes Action to Help Medicare Beneficiaries and Providers in Iowa and Indiana 2Health News:HHS Takes Action to Help Medicare Beneficiaries and Providers in Iowa and Indiana 3Health News:Human Factors International Sponsors Usability Professionals' Association (UPA) 2008 International Conference 2Health News:Human Factors International Sponsors Usability Professionals' Association (UPA) 2008 International Conference 3Health News:Future hope for patients with breast cancers resistant to tamoxifen 2Health News:Study underway to find an alternative cure for Crohn's disease and ulcerative colitis 2Health News:Gene Therapy Helps Dogs Stricken With Cancer 2Health News:Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic 2Health News:Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic 3
    ... Corneal biomechanical properties influence the ... and procedures, and may hold clues ... Until now, assessing the biomechanical properties ... possible, confining practitioners and researchers to ...
    ENDOlap™ suction and irrigation trumpet valves...
    Stryker Endoscopy offers a superior selection of probes and tips that interface with our suction and irrigation system....
    Corson Suction-Irrigation Probes are designed to provide flexibility and reliability in a disposable probe....
    Medicine Products: